This study is being done to determine if a drug called gabapentin helps in the postoperative
management of patients undergoing hip and knee operations. The investigators wish to
determine the effect of gabapentin on pain and sleep following surgery. If we can lessen a
patient's pain and improve sleep, the patient will be better able to participate in their
physical therapy. Gabapentin has already been shown to lessen postoperative pain when given
before surgery. In healthy patients, it has also been shown to improve certain aspects of
sleep. We hope to identify the effect of the drug, when given after surgery, on patients'
pain and sleep.
Intra Incisional Infiltration of Bupivacaine Versus Meloxicam on Post Cesarean Section Pain Relief
Completed
Menoufia University
N/A
2019-03-03
Investigation: compare the effect of local infiltration of incision site with bupivacaine and
local infiltration with meloxicam in women undergoing cesarean sections on postoperative pain
relief and analgesic requirement.
Condition: post cesarean sections analgesia intervention: infiltration of incision
bupivacaine versus meloxicam Phase: Not applicable
Periarticular Bupivacaine + Meloxicam ER Solution Versus Standard Practice During Total Knee Arthroplasty
Enrolling by invitation
Mayo Clinic
Phase 4
2022-01-01
The purpose of this study is to compare an FDA-approved medication for post-operative pain
control (HTX-011) to the standard of care institutional practice for periarticular analgesia
after primary total knee arthroplasty (weight based dosing of Ropivacaine, epinephrine and
ketorolac diluted with saline). We are doing this research study to find out if this new
medication provides superior pain control within 72 hours following surgery.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.